home > pmps

Pharmaceutical Manufacturing and Packing Sourcer


Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision-makers within the industry, identifying new trends and marketing opportunities as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharmaceutical, biotech, nutritional and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.

For further information please contact:

Nicholas Matthews

Amy McKavanagh

We're also on Twitter! Follow us @PMPSmag  

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.

Click here to view the digital version of PMPS


  Click here to view the digital version of Inhalation Technology

Featured in this issue
Thermal Protection Solutions

Protective Packaging

Kevin Valentine at TP3 Global and Cool Logistics India advises on factors to consider when selecting thermal protection covers to ensure seamless distribution of temperature-sensitive pharmaceuticals.
Formulations, Ingredients and Excipients
Orally Disintegrating Tablet Challenges

Dissolvable Development

Dr Carolina Diaz Quijano at Omya International demonstrates how functionalised calcium carbonate improves compatibility and disintegration time in orally dispersible tablets.
  Anti-Counterfeiting and Serialisation
Q&A: The Falsified Medicines Directive

Controlled Conduct

As the introduction of the new Falsified Medicines Directive approaches, Accord Healthcare’s Sandra Lee tells PMPS why serialisation is important and how the industry can prepare for the changes.

Edited by
Randice Altschul
Chief Executive Officer at Pop Test and Palisades Therapeutics

Published quarterly in
February, May,
August and November

Widgets Magazine <style type="text/css" media="screen"> </style> <script async='async' src=''> <script> var googletag = googletag || {}; googletag.cmd = googletag.cmd || []; </script> <script> googletag.cmd.push(function() { googletag.defineSlot('/57263142/Denny_Bros', [200, 150], 'div-gpt-ad-1523520548122-0').addService(googletag.pubads()); googletag.pubads().enableSingleRequest(); googletag.enableServices(); }); </script> </head> <!-- /57263142/Denny_Bros --> <div id='div-gpt-ad-1523520548122-0' style='height:150px; width:200px;'> <script> googletag.cmd.push(function() { googletag.display('div-gpt-ad-1523520548122-0'); }); </script> </div>
Widgets Magazine

Widgets Magazine
Industry Events

BioPharm America 2018

5-6 September 2018, Hynes Convention Center

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
More info >>

News and Press Releases

Wickham Laboratories to present at Cleanroom Technology Conference 2018

We are pleased to announce our CEO, Dr John McKenzie, will be presenting on ‘Microbiological Considerations in Cleanroom Validation’ at the Cleanroom Technology Conference to be held 16th-17th May, 2018.
More info >>

air transport logo


White Papers

Delivering Fit For Purpose Biomanufacturing CHO Cell Lines

Fujifilm Diosynth Biotechnologies

The challenge during mammalian cell line development is to identify and isolate stable, high expressing cell lines producing product with the appropriate critical product quality attributes rapidly, reproducibly and with relative ease. Obtaining a host cell line that inherently exhibits desirable biomanufacturing attributes can therefore have a significantly positive effect on the identification of recombinant cell lines with desired traits during cell line development screens. In this study, we demonstrate that it is possible to exploit intrinsic heterogeneity within host cell populations and identify host cell lines which are more “fit for purpose”.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement